Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart - PubMed

Affiliations

• PMID: 26611206
• DOI: 10.1007/s00395-015-0521-6

Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart

Ábel Perjés et al. Basic Res Cardiol. 2016 Jan.

Abstract

The G protein-coupled apelin receptor regulates important processes of the cardiovascular homeostasis, including cardiac development, cardiac contractility, and vascular tone. Most recently, a novel endogenous peptide ligand for the apelin receptor was identified in zebrafish, and it was named apela/elabela/toddler. The peptide was originally considered as an exclusively embryonic regulator, and so far its function in the adult organism remains elusive. We show here that apela is predominantly expressed in the non-cardiomyocyte fraction in the adult rodent heart. We also provide evidence that apela binds to apelin receptors in the heart. Using isolated adult rat hearts, we demonstrate, that just like the fellow receptor agonist apelin, apela increases cardiac contractility and induces coronary vasodilation already in the nanomolar level. The inotropic effect, as revealed by Western blot analysis, is accompanied by a significant increase in extracellular signal-regulated kinase (ERK) 1/2 phosphorylation. Pharmacological inhibition of ERK1/2 activation markedly attenuates the apela-induced inotropy. Analysis of samples from infarcted mouse hearts showed that expression of both apela and apelin receptor is induced in failing mouse hearts and correlate with left ventricular ejection fraction. Hence, we conclude that apela is present in the adult heart, is upregulated in post-infarction cardiac remodeling, and increases cardiac contractility in an ERK1/2-dependent manner.

Keywords: Apela; Cardiovascular; Cell signaling; Contractility; Extracellular signal-regulated kinase (ERK); G protein-coupled receptor (GPCR); Heart failure; Myocardial infarction; Peptides.

Similar articles

• Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.

  Deng C, Chen H, Yang N, Feng Y, Hsueh AJ. Deng C, et al. J Biol Chem. 2015 Jul 24;290(30):18261-8. doi: 10.1074/jbc.M115.648238. Epub 2015 May 20. J Biol Chem. 2015. PMID: 25995451 Free PMC article.

• Apelin increases cardiac contractility via protein kinase Cε- and extracellular signal-regulated kinase-dependent mechanisms.

  Perjés Á, Skoumal R, Tenhunen O, Kónyi A, Simon M, Horváth IG, Kerkelä R, Ruskoaho H, Szokodi I. Perjés Á, et al. PLoS One. 2014 Apr 2;9(4):e93473. doi: 10.1371/journal.pone.0093473. eCollection 2014. PLoS One. 2014. PMID: 24695532 Free PMC article.

• Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.

  Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, Upton PD, Crosby A, Sawiak SJ, Carpenter TA, Glen RC, Morrell NW, Maguire JJ, Davenport AP. Yang P, et al. Circulation. 2017 Mar 21;135(12):1160-1173. doi: 10.1161/CIRCULATIONAHA.116.023218. Epub 2017 Jan 30. Circulation. 2017. PMID: 28137936 Free PMC article.

• The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.

  Japp AG, Newby DE. Japp AG, et al. Biochem Pharmacol. 2008 May 15;75(10):1882-92. doi: 10.1016/j.bcp.2007.12.015. Epub 2008 Jan 5. Biochem Pharmacol. 2008. PMID: 18272138 Review.

• Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.

  Kuba K, Sato T, Imai Y, Yamaguchi T. Kuba K, et al. Peptides. 2019 Jan;111:62-70. doi: 10.1016/j.peptides.2018.04.011. Epub 2018 Apr 21. Peptides. 2019. PMID: 29684595 Review.

Cited by

• Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients.

  Kaplan M, Yavuz F, Kaplan GI, Bursa N, Vuruşkan E, Sucu M. Kaplan M, et al. Anatol J Cardiol. 2021 May;25(5):330-337. doi: 10.14744/AnatolJCardiol.2020.17329. Anatol J Cardiol. 2021. PMID: 33960308 Free PMC article.

• Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes-A Pilot Study.

  Diakowska D, Wyderka R, Krzystek-Korpacka M, Osuch Ł, Leśków A, Sołtowska A, Stanek M, Rosińczuk J, Jaroch J. Diakowska D, et al. J Clin Med. 2021 Sep 26;10(19):4420. doi: 10.3390/jcm10194420. J Clin Med. 2021. PMID: 34640437 Free PMC article.

• The impact of the apelinergic system in coronary collateral formation.

  Özsoyler İ, Uçak HA, Badak TO, Çakallıoğlu A, Bayraktar M, Arslan AS. Özsoyler İ, et al. Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Apr 7;31(2):192-198. doi: 10.5606/tgkdc.dergisi.2023.24422. eCollection 2023 Apr. Turk Gogus Kalp Damar Cerrahisi Derg. 2023. PMID: 37484641 Free PMC article.

• The apelinergic system as an alternative to catecholamines in low-output septic shock.

  Coquerel D, Sainsily X, Dumont L, Sarret P, Marsault É, Auger-Messier M, Lesur O. Coquerel D, et al. Crit Care. 2018 Jan 19;22(1):10. doi: 10.1186/s13054-018-1942-z. Crit Care. 2018. PMID: 29347994 Free PMC article.

• The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.

  Liu Y, Wang L, Shi H. Liu Y, et al. Hypertens Res. 2019 Jul;42(7):928-934. doi: 10.1038/s41440-018-0193-3. Epub 2019 Jan 9. Hypertens Res. 2019. PMID: 30626933 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Molecular Biology Databases

  • Gene Ontology
  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal